ARTICLE | Company News
InterMune and Boehringer in interferon deal
March 26, 2001 8:00 AM UTC
ITMN will develop and market interferon gamma-1b under Boehringer Ingelheim's trade name Imukin in all countries outside of the U.S., Canada and Japan. ITMN already has rights to develop and market in...